Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Completed
Conditions studied: Precancerous Condition
In brief
RATIONALE: A study that evaluates DNA changes and other disease-related health information in patients with Barrett's esophagus, gastroesophageal reflux, or gastrointestinal bleeding may help doctors learn more about the risk factors for Barrett's esophagus. PURPOSE: This clinical trial is looking at DNA changes and other disease-related health information as risk factors for Barrett's esophagus in patients with Barrett's esophagus, gastroesophageal reflux, or gastrointestinal bleeding.
Key facts
- Study ID
- NCT00445653
- Run by
- Massachusetts General Hospital
- People needed
- 170
- Starts
- 2005-08-01
- Expected to finish
- 2013-03-01
- Last updated by the study team
- 2017-01-18
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
- Harvard School of Public Health — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.